Russell Investments Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
66,355
+60,698
+1,073% +$148K ﹤0.01% 3261
2026
Q1
$13.4K Hold
5,657
﹤0.01% 3723
2025
Q4
$29.3K Sell
5,657
-31,467
-85% -$152K ﹤0.01% 3497
2025
Q3
$158K Sell
37,124
-131,028
-78% -$609K ﹤0.01% 2879
2025
Q2
$617K Buy
168,152
+45,021
+37% +$168K ﹤0.01% 2260
2025
Q1
$547K Buy
+123,131
New +$497K ﹤0.01% 2269
2024
Q3
Sell
-6,523
Closed -$18.3K 3764
2024
Q2
$18.3K Buy
6,523
+3,583
+122% +$9.62K ﹤0.01% 2960
2024
Q1
$8.35K Buy
+2,940
New +$9.99K ﹤0.01% 2871
2023
Q3
Sell
-76,677
Closed -$255K 3598
2023
Q2
$255K Sell
76,677
-5,460
-7% -$16.1K ﹤0.01% 2417
2023
Q1
$175K Buy
82,137
+79,877
+3,534% +$197K ﹤0.01% 2502
2022
Q4
$6.08K Sell
2,260
-57,001
-96% -$166K ﹤0.01% 2857
2022
Q3
$191K Buy
59,261
+46,100
+350% +$208K ﹤0.01% 2551
2022
Q2
$64K Sell
13,161
-25,749
-66% -$158K ﹤0.01% 2722
2022
Q1
$295K Buy
38,910
+6,900
+22% +$53.4K ﹤0.01% 2375
2021
Q4
$294K Sell
32,010
-159,110
-83% -$1.69M ﹤0.01% 2611
2021
Q3
$2.72M Buy
191,120
+37,939
+25% +$589K ﹤0.01% 1647
2021
Q2
$2.54M Buy
153,181
+101,367
+196% +$1.89M ﹤0.01% 1770
2021
Q1
$942K Buy
51,814
+40,913
+375% +$554K ﹤0.01% 2270
2020
Q4
$82K Sell
10,901
-29,487
-73% -$140K ﹤0.01% 2879
2020
Q3
$155K Buy
+40,388
New +$159K ﹤0.01% 2870

Other funds holding ORGO

Russell Investments Group's ORGO Position: Q2 2026 in Review

Russell Investments Group increased its Organogenesis Holdings (ORGO) stake by 1,073% in Q2 2026, buying an estimated $148K and bringing the position to 66,355 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3261.

Russell Investments Group first reported a position in ORGO in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.72M in Q3 2021. 48 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Russell Investments Group held 66,355 shares of Organogenesis Holdings worth $161K as of Q2 2026.
  • Russell Investments Group bought 60,698 Organogenesis Holdings shares in Q2 2026, an estimated $148K.
  • Organogenesis Holdings made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3261 holding.
  • Russell Investments Group first reported a position in Organogenesis Holdings in Q3 2020 and has held it in 20 quarters since.
  • Russell Investments Group's Organogenesis Holdings position peaked at $2.72M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.